MIP Discovery announces drugs of abuse reagent launch.

By Keli Stockbridge

MIP Discovery announces drugs of abuse reagent launch Novel nanoMIPTM affinity reagents engineered to recognise metabolites of the synthetic opioid, fentanyl are now available for research evaluation.  It is hoped that these reagents will help combat the growing wave of deaths in North America attributable to synthetic opioids.